SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway
Open Access
- 10 September 2021
- Vol. 23 (10) , 1037-1047
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 44 references indexed in Scilit:
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerNature Genetics, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Molecular genetics of prostate cancer: new prospects for old challengesGenes & Development, 2010
- Phosphorylation and Activation of Cell Division Cycle Associated 5 by Mitogen-Activated Protein Kinase Play a Crucial Role in Human Lung CarcinogenesisCancer Research, 2010
- Structures of SPOP-Substrate Complexes: Insights into Molecular Architectures of BTB-Cul3 Ubiquitin LigasesMolecular Cell, 2009
- Sororin Is Required for Stable Binding of Cohesin to Chromatin and for Sister Chromatid Cohesion in InterphaseCurrent Biology, 2007
- Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent mannerCancer Cell, 2006
- Sororin, a Substrate of the Anaphase- Promoting Complex, Is Required for Sister Chromatid Cohesion in VertebratesMolecular Cell, 2005
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2002
- GENE THERAPY FOR PROSTATE CANCER: WHERE ARE WE NOW?Journal of Urology, 2000